Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.42 |
| ▸ | BBOX1 | O75936 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GRK2 | P25098 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL867206 | 0.96 | BBOX1 (0.47) | TSHRBBOX1HPGDALDH1A1CYP3A4 | |
| SCHEMBL16799361 | 0.93 | TSHR (0.49) | TSHRBBOX1HPGDALDH1A1CYP3A4 | |
| SCHEMBL16798842 | 0.93 | TSHR (0.49) | TSHRBBOX1HPGDALDH1A1CYP3A4 | |
| SCHEMBL18151515 | 0.93 | TSHR (0.49) | TSHRBBOX1HPGDALDH1A1CYP3A4 | |
| SCHEMBL16798967 | 0.93 | TSHR (0.49) | TSHRBBOX1HPGDALDH1A1CYP3A4 | |
| SCHEMBL16798961 | 0.93 | TSHR (0.49) | TSHRBBOX1HPGDALDH1A1CYP3A4 | |
| SCHEMBL16799249 | 0.93 | TSHR (0.49) | TSHRBBOX1HPGDALDH1A1CYP3A4 | |
| SCHEMBL16799372 | 0.91 | TSHR (0.50) | TSHRBBOX1HPGDALDH1A1CYP3A4 | |
| SCHEMBL16799087 | 0.90 | TSHR (0.53) | TSHRBBOX1HPGDALDH1A1CYP3A4 | |
| SCHEMBL18151644 | 0.90 | TSHR (0.53) | TSHRBBOX1HPGDALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11535588-B2 | Hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid | SPCM SA (FR) | 2022-12-27 | — | — | US | claimed |
| US-20220289672-A1 | HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID | SPCM SA (FR) | 2022-09-15 | — | — | US | claimed |
| EP-4739839-A1 | DIALDEHYDE POLYMER PRODUCTION PROCESS | SNF Group (FR) | 2026-05-13 | — | — | EP | disclosed |
| US-12545747-B2 | Method, kit, and device for preparing glycan from glycoprotein | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2026-02-10 | — | — | US | disclosed |
| EP-4680578-A1 | MODULABLE METHOD FOR TREATING AN AQUEOUS EFFLUENT | SNF Group (FR) | 2026-01-21 | — | — | EP | disclosed |
| US-12516235-B2 | Cementitious composition comprising a polymeric micro-gel as an anti-gas migration agent | SNF GROUP (FR) | 2026-01-06 | — | — | US | disclosed |
| EP-4638537-A1 | HYBRID POLYMER AND METHOD FOR OBTAINING SAME | SNF Group (FR) | 2025-10-29 | — | — | EP | disclosed |
| WO-2025082989-A1 | OLIGO-INITIATOR AND ITS USE FOR PRODUCING WATER-SOLUBLE HYBRID POLYMERS | SNF GROUP (FR) | 2025-04-24 | — | — | WO | disclosed |
| WO-2025070814-A1 | SUGAR CHAIN PREPARATION METHOD AND SUGAR CHAIN ANALYSIS METHOD | 住友ベークライト株式会社 | 2025-04-03 | — | — | WO | disclosed |
| EP-4514866-A1 | POLYMER AND USE THEREOF AS A HYDROCARBON VISCOSITY REDUCING AGENT | SNF Group (FR) | 2025-03-05 | — | — | EP | disclosed |
| WO-2025040784-A1 | WATER-SOLUBLE POLYMER AS BATTERY BINDING MATERIAL | SNF GROUP (FR) | 2025-02-27 | — | — | WO | disclosed |
| EP-3601222-A1 | FRACTURING FLUID COMPRISING A (CO)POLYMER OF A HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULPHONIC ACID AND HYDRAULIC FRACTURING METHOD | S.P.C.M. SA (FR) | 2020-02-05 | — | — | EP | disclosed |
| EP-3601220-A1 | ENHANCED OIL RECOVERY METHOD USING A (CO)POLYMER OF A HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID | S.P.C.M. SA (FR) | 2020-02-05 | — | — | EP | disclosed |
| US-20200031765-A1 | HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID | S.P.C.M. SA (FR) | 2020-01-30 | — | — | US | disclosed |
| US-20190345373-A1 | COMPOSITION FOR OIL AND GAS RECOVERY | S.P.C.M. SA (FR) | 2019-11-14 | — | — | US | disclosed |
| WO-2018172683-A1 | METHOD FOR TREATING A SUSPENSION OF SOLID PARTICLES IN WATER USING A (CO)POLYMER OF A HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANESULFONIC ACID | S.P.C.M. SA (FR) | 2018-09-27 | — | — | WO | disclosed |
| WO-2018172676-A1 | CRYSTALLINE FORM HYDRATED WITH 2-ACRYLAMIDO-2-METHYLPROPANE SULPHONIC ACID | S.P.C.M. SA (FR) | 2018-09-27 | — | — | WO | disclosed |
| WO-2018172684-A1 | FRACTURING FLUID COMPRISING A (CO)POLYMER OF A HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULPHONIC ACID AND HYDRAULIC FRACTURING METHOD | S.P.C.M. SA (FR) | 2018-09-27 | — | — | WO | disclosed |
| WO-2018172682-A1 | ENHANCED OIL RECOVERY METHOD USING A (CO)POLYMER OF A HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID | S.P.C.M. SA (FR) | 2018-09-27 | — | — | WO | disclosed |
| US-20150219641-A1 | ANALYSIS CARRIER AND MANUFACTURING METHOD AND USE METHOD THEREFOR | SUMITOMO BAKELITE CO., LTD. (JP) | 2015-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220289672-A1 | HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID | SFN, H1-2, H1-0 | TSHR 3902/4885BBOX1 4421/4885HPGD 3814/4885 |
| US-11535588-B2 | Hydrated crystalline form of 2-acrylamido-2-methylpropane sulfonic acid | SFN, H1-2, H1-0 | TSHR 3902/4885BBOX1 4421/4885HPGD 3814/4885 |
| US-20200031765-A1 | HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID | SFN, H1-2, H1-0 | TSHR 3902/4885BBOX1 4421/4885HPGD 3814/4885 |
| US-12545747-B2 | Method, kit, and device for preparing glycan from glycoprotein | FUT7, FUT4, SIGLEC7 | TSHR 565/4885BBOX1 790/4885HPGD 3202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.